Washing the chest with antifungals: a new hope for deadly fungal infections?
NCT ID NCT07337993
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether washing the chest cavity with the antifungal drug voriconazole can help treat a rare but serious fungal infection of the lung lining. It includes 50 patients who either get the wash before surgery or as a standalone treatment if they are too sick for surgery. The goal is to see if this approach improves lung expansion and reduces complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- voriconazole
- What this could lead to
- If it works, this could offer a less invasive treatment option for fungal chest infections, especially for patients too sick for surgery.
- What could go wrong
- This is a small, early study with only 50 participants. It may not show clear benefits, and there are risks like allergic reactions or complications from the procedure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUNGAL INFECTION LUNGS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Services Hospital Lahore
RECRUITINGLahore, Punjab Province, 54000, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.